Skip to content

Clinical trials

Observational Purpura, Thrombocytopenic, Idiopathic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Observational Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20113
20121
20131
20161
20172
20181
20201
20212
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed4
Withdrawn3
Not yet recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shandong University7
Peking University People's Hospital4
First Affiliated Hospital of Suzhou Medical College2
Ming Hou2
Institute of Hematology & Blood Diseases Hospital, China1
RenJi Hospital1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic18
Anemia, Aplastic1
Disseminated Intravascular Coagulation1
Hemophilia A1
Hemophilia B1
Hemostatic Disorders1
Neuroblastoma1
Pulmonary Embolism1
Purpura, Thrombotic Thrombocytopenic1
Thrombophilia1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.